Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
| Brand name | ENALAPRIL MALEATE |
| Generic name | ENALAPRIL MALEATE |
| Active ingredient(s) | ENALAPRIL MALEATE |
| Distributed by / for | Rising Pharma Holdings, Inc., East Brunswick, NJ 08816 |
| NDC | 64980-688-10 |
| Full product label | Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10. |
| Recalling firm | JB Chemicals and Pharmaceuticals Ltd |
| Distribution | Nationwide in the USA |
| Quantity | 675 bottles |
| Recall initiated | 2026-04-23 |
| Report date | 2026-05-13 |
| Recall completed | — |
| Recall number | D-0520-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Mumbai India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗